PolyNovo Limited (ASX:PNV)
1.170
+0.040 (3.54%)
Apr 24, 2025, 4:10 PM AEST
PolyNovo Revenue
PolyNovo had revenue of 59.54M AUD in the half year ending December 31, 2024, with 102.62% growth. This brings the company's revenue in the last twelve months to 115.58M, up 38.47% year-over-year. In the fiscal year ending June 30, 2024, PolyNovo had annual revenue of 103.23M with 57.20% growth.
Revenue (ttm)
115.58M
Revenue Growth
+38.47%
P/S Ratio
6.99
Revenue / Employee
409.85K
Employees
254
Market Cap
808.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 103.23M | 37.56M | 57.20% |
Jun 30, 2023 | 65.67M | 23.78M | 56.76% |
Jun 30, 2022 | 41.89M | 12.55M | 42.78% |
Jun 30, 2021 | 29.34M | 7.15M | 32.19% |
Jun 30, 2020 | 22.19M | 8.15M | 58.03% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |
PolyNovo News
- 6 weeks ago - PolyNovo chief executive steps down after dispute with chairman - The Australian Financial Review
- 6 weeks ago - David Williams says he makes no apologies for ‘aggressive’ style - The Australian Financial Review
- 8 months ago - Polynovo Ltd (CALZF) (Q4 2024) Earnings Call Transcript Highlights: Record Revenue and ... - GuruFocus